Intrinsic Value of S&P & Nasdaq Contact Us

Enhabit, Inc. EHAB NYSE

NYSE • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
27/100
0/7 Pass
SharesGrow Intrinsic Value
$9.47
-32.1%
Analyst Price Target
$13.53
-2.9%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Enhabit, Inc. (EHAB) has a negative trailing P/E of -154.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 23.1 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -0.65%, forward earnings yield 4.33%.

Criteria proven by this page:

  • VALUE (35/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -154.0); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -0.65%).
  • Forward P/E 23.1 — analysts expect a return to profitability with estimated EPS of $0.60 for FY2026.
  • Trailing Earnings Yield -0.65% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 4.33% as earnings recover.
  • Analyst consensus target $13.53 (-2.9% downside) — slight downside risk — the market may be ahead of analyst expectations.

Overall SharesGrow Score: 27/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
27/100
SG Score
View full scorecard →
VALUE
35/100
Price-to-Earnings & upside
Proven by this page
FUTURE
26/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
52/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — EHAB

Valuation Multiples
P/E (TTM)-154.0
Forward P/E23.1
PEG RatioN/A
Forward PEGN/A
P/B Ratio1.33
P/S Ratio0.67
EV/EBITDA13.5
Per Share Data
EPS (TTM)$-0.09
Forward EPS (Est.)$0.60
Book Value / Share$11.13
Revenue / Share$20.91
FCF / Share$1.30
Yields & Fair Value
Earnings Yield-0.65%
Forward Earnings Yield4.33%
Dividend Yield0.00%
SharesGrow IV$9.47 (-32.1%)
Analyst Target$13.53 (-2.9%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2019 4.1 0.00 0.00 0.09 5.03%
2020 1.3 0.01 0.07 0.09 148.21%
2021 0.9 0.02 0.07 0.09 158.05%
2022 -16.3 0.17 0.89 0.62 99.33%
2023 -6.4 0.03 0.77 0.50 -
2024 -2.5 -0.03 0.75 0.38 -
2025 -101.8 1.05 0.88 0.44 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $6.15 $1.09B $24M 2.2%
2020 $19.23 $1.08B $75M 7%
2021 $28.49 $1.11B $111.1M 10%
2022 $1.25 $1.08B $-40.4M -3.7%
2023 $-1.61 $1.05B $-80.5M -7.7%
2024 $-3.11 $1.03B $-156.2M -15.1%
2025 $-0.09 $1.06B $-4.6M -0.4%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.60 $0.57 – $0.65 $1.1B $1.09B – $1.11B 3
2027 $0.64 $0.61 – $0.68 $1.15B $1.13B – $1.18B 3
2028 $0.62 $0.50 – $0.74 $1.16B $1.12B – $1.2B 2
2029 $0.30 $0.30 – $0.30 $1.34B $1.32B – $1.35B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message